Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Blood Neoplasia|August 14, 2025
Checkpoint immunotherapy is associated with preferential activation of tumor antigen-specific CD4+ T cells in MDSElizabeth A Griffiths, Pragya Srivastava, Eduardo Cortes Gomez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2023
Allogeneic Hematopoietic Cell Transplantation Improves Outcome in Myelodysplastic Syndrome Across High-Risk Genetic Subgroups: Genetic Analysis of the Blood and Marrow Transplant Clinical Trials Network 1102 StudyJurjen Versluis, Wael Saber, Harrison K Tsai, et al.
Medrxiv : the Preprint Server for Health Sciences|August 14, 2023
Measurable Residual IDH1 before Allogeneic Transplant for Acute Myeloid LeukemiaGege Gui, Laura W Dillon, Niveditha Ravindra, et al.
JAMA Oncology|May 2, 2024
Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid LeukemiaLaura W Dillon, Gege Gui, Niveditha Ravindra, et al.
Bone Marrow Transplantation|October 25, 2024
Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemiaGege Gui, Niveditha Ravindra, Pranay S Hegde, et al.
Bone Marrow Transplantation|November 6, 2024
Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemiaGege Gui, Niveditha Ravindra, Pranay S Hegde, et al.
Pageof 9